Hyperglycemia-driven signaling bridges between diabetes and cancer
Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity
Discuss your complete medical history , particularly: Personal or family history of thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 History of pancreatitis or severe gastrointestinal disease Kidney function status Other endocrine conditions, including diabetes complications Your doctor may coordinate care with specialists such as an endocrinologist, particularly if you have complex thyroid disease or difficult-to-control diabetes
Brouwer Clinical Pharmacology & Therapeutics .2026;[Epub] CrossRef Divergent risk profiles for cause-specific mortality in MASLD and MetALD: a nationwide population-based study Hyuk Kim, Jeong-Ju Yoo, Young Chang, Jae Young Jang, Tom Ryu, Soung Won Jeong, Sang Gyune Kim, Young Seok Kim, Suyeon Park Frontiers in Medicine .2026;[Epub] CrossRef Therapeutic Effects of Glucagon-like Peptide-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: A Systematic Review Dina Mahoon, Fares Kellany, Imad Khan, Somieya Khan, Alexandra E
GLP-1 is a hormone released by intestinal L-cells [1]